Skip to main content
. 2022 Nov 17;9(11):1764. doi: 10.3390/children9111764

Table 1.

Demographic and clinical variables of the study population. Abbreviations: TNFi mAb, tumor necrosis factor inhibitor (monoclonal antibody).

Feature Healthy Controls Juvenile Spondyloarthritis
n 6 5
Demographics
Male Sex 2 (33%) 1 (20%)
Race
 White 5 (83%) 5 (100%)
 Black 1 (17%) 0
Age (years) 14.4 ± 2.1 14.3 ± 2.0
Treatment
 Etanercept 0 1 (20%)
 TNFi mAb 0 3 (60%)
 Abatacept 0 1 (20%)